Advanced Technology Co KSCP

The company’s capital structure is highly leveraged, with a debt-to-equity ratio of 2.77, indicating significant reliance on debt financing. Despite holding KWD 7.34 million in cash and equivalents, the firm’s long-term debt of KWD 199.34 million suggests a liquidity risk, as net cash is negative after subtracting total debt. Free cash flow is negative at KWD 9,300, and capital expenditures of KWD 2.14 million were made in the period, further straining liquidity.

Profitability metrics are weak, with a return on equity of 0.08% and a return on assets of 0.02%, both far below typical thresholds for healthy performance in the medical equipment and distribution industry. Operating income of KWD 2.25 million and net income of KWD 58,940 suggest minimal profitability, with a gross margin of 26.57% (KWD 10.88 million gross profit on KWD 40.94 million revenue) that is likely insufficient to cover operating and financial costs.

Geographic and segment exposure is not explicitly detailed in the available data, but the firm operates as a single entity within the medical equipment and distribution industry. Revenue concentration is not disclosed, but the absence of segment reporting implies a lack of diversification.

Growth appears stagnant, with no clear trajectory provided in the outlook. The firm’s operating cash flow of KWD 9.54 million is modest and does not support significant reinvestment or expansion. The lack of positive revenue growth or margin expansion in the financials suggests limited near-term upside.

Risk factors include high leverage and weak profitability, with a debt-to-equity ratio of 2.77 and a current ratio of 1.32, both signaling liquidity and solvency concerns. Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding, and no recent equity issuance disclosed.

Recent events or filings are not detailed in the available data, but the firm’s financials suggest a need for operational or strategic adjustments to improve profitability and reduce debt exposure.

Operating margin of 5.49% significantly exceeds the 3.11% cohort median, indicating superior operational efficiency relative to peers.

Cash conversion of 161.87% ranks best-in-class, vastly outperforming the 0.84% cohort median for capital generation.

Gross profit reached 30.9 million KWD in FY0, maintaining a substantial buffer despite the net loss incurred.

Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.

Debt-to-equity ratio of 2.77 sits in the bottom quartile, indicating excessive leverage compared to the 0.20 cohort median.

Return on equity of 0.08% trails the 1.42% cohort median, reflecting extremely poor capital efficiency for shareholders.

High credit risk flags suggest significant potential for default or financial distress given the company's current leverage profile.